Early Integrated Intervention in Severe Affective Disorders

This study has been completed.
Sponsor:
Collaborators:
Rigshospitalet, Denmark
Hvidovre University Hospital
Amager Hospital
Frederiksberg University Hospital
Bispebjerg Hospital
Information provided by (Responsible Party):
Lars Vedel Kessing, Hovedstadens Sygehusfaelesskab
ClinicalTrials.gov Identifier:
NCT00253071
First received: November 14, 2005
Last updated: March 17, 2012
Last verified: March 2012
  Purpose

The purpose of this study is to determine whether early integrated prophylactic combined medical and psychological outpatient treatment is associated with a better prognosis in patients with severe unipolar and bipolar affective disorders than standard treatment.


Condition Intervention
Depressive Disorder
Bipolar Disorder
Behavioral: Prophylactic combined medical and psychological treatment

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Early Integrated Intervention in Severe Affective Disorders - a Randomized Controlled Trial.

Resource links provided by NLM:


Further study details as provided by Hovedstadens Sygehusfaelesskab:

Primary Outcome Measures:
  • Time to re-admission [ Time Frame: 0-6 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Time to recurrence of an affective episode (depressive (MDI) or manic/mixed (MDQ)). [ Time Frame: 1 and 2 years ] [ Designated as safety issue: No ]

Enrollment: 426
Study Start Date: December 2005
Study Completion Date: March 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: A,2
No intervention: treatment as usual at a community psychiatric center, private psychiatrist or general practitioner.
Behavioral: Prophylactic combined medical and psychological treatment

Medical treatment is naturalistic and evidence based according to international recommendations.

Psychological treatment is either group psychoeducation or group cognitive behavioural therapy.

Experimental: A, 1

Behavioral: Prophylactic combined medical and psychological treatment

Medical treatment is naturalistic and evidence based according to international recommendations.

Psychological treatment is either group psychoeducation or group cognitive behavioural therapy.

Behavioral: Prophylactic combined medical and psychological treatment

Medical treatment is naturalistic and evidence based according to international recommendations.

Psychological treatment is either group psychoeducation or group cognitive behavioural therapy.


Detailed Description:

Patients who have been hospitalised for unipolar or bipolar disorder have a poor prognosis with highly increased risk of recurrence of episodes and increased risk of psychosocial dysfunction. It seems as integrated prophylactic combined medical and psychological out-patient treatment may lead to a better long-term prognosis in patients with affective disorders in general. It has not been specifically investigated whether such integrated treatment may improve long-term outcome if the intervention is offered early in the course of the affective illness.

Subjects: Patients currently discharged from first, second or third hospitalisation ever from psychiatric department with a diagnosis of severe single depressive episode/recurrent depression or with a diagnosis of manic/mixed episode or bipolar disorder.

Comparison: Early intervention with integrated prophylactic combined medical and psychological outpatient treatment as offered by a clinic for affective disorders compared with standard outpatient treatment as offered by community psychiatric centres, private specialists in psychiatry or general practitioners.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

1. Discharge diagnosis of severe single depressive episode, recurrent depression, manic/mixed episode or bipolar disorder

Exclusion Criteria:

  1. Moderate to severe dementia
  2. Incapable in understanding or reading danish
  3. Earlier randomised to the trial
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00253071

Locations
Denmark
Department of Psychiatry, University Hospital of Copenhagen, Denmark
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Hovedstadens Sygehusfaelesskab
Rigshospitalet, Denmark
Hvidovre University Hospital
Amager Hospital
Frederiksberg University Hospital
Bispebjerg Hospital
Investigators
Principal Investigator: Lars V kessing, Professor Department of psychiatry, University Hospital of Copenhagen, Denmark
  More Information

No publications provided by Hovedstadens Sygehusfaelesskab

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Lars Vedel Kessing, Professor, MD, Hovedstadens Sygehusfaelesskab
ClinicalTrials.gov Identifier: NCT00253071     History of Changes
Other Study ID Numbers: 31/04r
Study First Received: November 14, 2005
Last Updated: March 17, 2012
Health Authority: Denmark: National Board of Health

Keywords provided by Hovedstadens Sygehusfaelesskab:
Prophylactic treatment
Pharmacological treatment
Psychological treatment

Additional relevant MeSH terms:
Depressive Disorder
Depression
Bipolar Disorder
Disease
Mood Disorders
Mental Disorders
Behavioral Symptoms
Affective Disorders, Psychotic
Pathologic Processes

ClinicalTrials.gov processed this record on October 19, 2014